Last updated: July 11, 2026

Application No. 19/563,621

Untitled Application

Unknown

Filed

Priority

Nov 03, 2015 — provisional 62/250,016 +4 more

Examiner

DUFFY, BRADLEY

Art Unit

Tech Center

Janssen Biotech, Inc.

Assignee

Janssen Pharmaceuticals Inc.

OA Round

1 (Non-Final)

This examiner grants 55% of cases after interview

— +45.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 742 resolved cases, 2023–2026

Examiner Intelligence

DUFFY, BRADLEY View full profile →

Grants 55% of resolved cases

Career Allowance Rate

405 granted / 742 resolved

-5.4% vs TC avg

Strong +45% interview lift

Without

With

+45.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 9m

Avg Prosecution

39 currently pending

Career history

784

Total Applications

across all art units

Statute-Specific Performance

§101

1.1%

-38.9% vs TC avg

§103

40.8%

+0.8% vs TC avg

§102

11.2%

-28.8% vs TC avg

§112

21.4%

-18.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 742 resolved cases

Prosecution Timeline

Apr 16, 2026

Response after Non-Final Action

Jul 07, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/150,626

Patent 12662535

PRO-ANTIBODY THAT REDUCES OFF-TARGET TOXICITY

5y 5m to grant Granted Jun 23, 2026

17/998,733

Patent 12661396

SELECTIVE TARGETING OF THE TREML1/MD2 INTERACTION BY SMALL PEPTIDE OR PROTEIN AND ITS USE FOR VACCINE ADJUVANTS

3y 7m to grant Granted Jun 23, 2026

17/793,587

Patent 12655220

LIGAND-BINDING FUSION PROTEINS

3y 11m to grant Granted Jun 16, 2026

16/516,978

Patent 12636274

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR SYSTEMIC TREATMENT OF SOLID TUMORS

6y 10m to grant Granted May 26, 2026

17/172,700

Patent 12637515

BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF

5y 3m to grant Granted May 26, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

55%

Grant Probability

99%

With Interview (+45.3%)

3y 9m

Median Time to Grant

Low

PTA Risk

Based on 742 resolved cases by this examiner. Grant probability derived from career allowance rate.